Pirfenidone ameliorates liver steatosis by targeting the STAT3-SCD1 axis

ConclusionIn summary, our data reveal that PFD may play an important role in mitigating hepatic steatosis in a STAT3-SCD1-dependent manner.
Source: Inflammation Research - Category: Research Source Type: research